Quantitative capability and clinical usefulness of 11C-PiB-PET on known or suspected MCI patients

Quantitative capability and clinical usefulness of 11C-PiB-PET on known or suspected MCI patients - Quantitative capability and clinical usefulness of PiB-PET on MCI (PiB-WB)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004089

Enrollment

Registered

2010-08-24

Start date

2010-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MCI(mild cognitive impairment)

Interventions

PiB-PET

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with known or suspected MCI whom the referring physician considers that PiB-PET scan is clinically useful

Exclusion criteria

Exclusion criteria: 1) Cannot keep supine position for 100min 2) Large cerebral hemorrhage or infarction on MRI 3) Possibility of incomplete scan 4) Too much radiation exposure 5) Unsuitable for anyother reasons

Design outcomes

Primary

Measure	Time frame
1.Whole-body distribustion of PiB in the early Phase 2.Cortical deposition of PiB in the late phase	—

Countries

Japan

Contacts

Public ContactMichio Senda

Institute of Biomedical Research and Innovation Division of Molecular Imaging

senda@fbri.org078-304-5212

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026